| | |
| Study questions FDA's shorter drug approval times Monday, Oct 28, 2013 09:54 PM PDT By Toni Clarke WASHINGTON (Reuters) - New drugs that receive expedited review by the Food and Drug Administration are being tested on fewer patients, leaving many safety questions unanswered even after they are approved, a study released on Monday in the Journal of the American Medical Association found. Study authors Thomas Moore of the Institute for Safe Medication Practices and Dr Curt Furberg, a professor at Wake Forest School of Medicine, examined the development times, clinical testing and risks associated with 20 new drugs approved in 2008. ... Full Story | Top |
| Judge blocks part of Texas law restricting abortion Monday, Oct 28, 2013 04:46 PM PDT  By Karen Brooks AUSTIN, Texas (Reuters) - A federal judge on Monday blocked the provision of a sweeping new Texas abortion law that requires doctors performing the procedure to have an agreement with a local hospital to admit patients, handing a partial victory to supporters of the right to abortion. The Texas law was the most fiercely debated proposal to restrict such procedures in the United States this year. ... Full Story | Top |
| JAMA study questions FDA's shorter drug approval times Monday, Oct 28, 2013 03:23 PM PDT By Toni Clarke WASHINGTON (Reuters) - New drugs that receive expedited review by the Food and Drug Administration are being tested on fewer patients, leaving many safety questions unanswered even after they are approved, a study released on Monday in the Journal of the American Medical Association found. Study authors Thomas Moore of the Institute for Safe Medication Practices and Dr Curt Furberg, a professor at Wake Forest School of Medicine, examined the development times, clinical testing and risks associated with 20 new drugs approved in 2008. ... Full Story | Top |
| Insight: Delays, clashes hinder attempts to salvage Batista's OGX Monday, Oct 28, 2013 02:55 PM PDT  By Guillermo Parra-Bernal, Jeb Blount and Nick Brown SAO PAULO/RIO DE JANEIRO/NEW YORK (Reuters) - Attempts to save Eike Batista's flagship oil company, the business most responsible for the meltdown of his once high-flying industrial empire, have been hampered by internal conflict and unpredictable decisions by the Brazilian tycoon, sources with direct knowledge of the situation told Reuters. ... Full Story | Top |
| Ohio to use execution drugs combination never tried in U.S Monday, Oct 28, 2013 02:31 PM PDT By Kim Palmer CLEVELAND (Reuters) - Ohio said on Monday that it does not have enough of the drug pentobarbital to carry out a scheduled execution next month and will turn to a combination of two drugs that a death-penalty expert said has never been used before in the United States. Ohio is the latest of several U.S. states looking to new suppliers or new drugs for use in lethal injections. With major pharmaceutical companies discouraging use of their products in executions, these states have tapped lightly regulated "compounding pharmacies" or turned to new drugs for executions. ... Full Story | Top |
| Poverty, parenting linked to child brain development Monday, Oct 28, 2013 01:41 PM PDT By Andrew M. Seaman NEW YORK (Reuters Health) - Children who grow up in poor families may have smaller brains than their more well-off peers, says a new study. But good parenting may help overcome that disadvantage. Researchers found that kids who grew up poor tended to have smaller hippocampus and amygdala volumes. Those areas of the brain are partly responsible for regulating memory and emotions. "Generally speaking, larger brains within a certain range of normal are healthier brains," Dr. Joan Luby, the study's lead author, said. ... Full Story | Top |
| HealthCare.gov up again after data system crash, may be slow: agency Monday, Oct 28, 2013 12:18 PM PDT  By Caroline Humer and Sharon Begley NEW YORK (Reuters) - The website at the center of the U.S. healthcare reform law was back up Monday after a data center outage prevented Americans from enrolling in subsidized health insurance, the latest technical problem to plague the online insurance exchanges. The outage, which started before dawn on Sunday, affected not only the federal government's online exchange, HealthCare.gov, but also those run by 14 states and the District of Columbia, the Department of Health and Human Services said. ... Full Story | Top |
| Vatican's 'culture minister' tweets Lou Reed song Monday, Oct 28, 2013 11:49 AM PDT  VATICAN CITY (Reuters) - Cardinal Gianfranco Ravasi, the Vatican's 71-year-old culture minister, paid his own tribute on Monday to the late rocker Lou Reed, tweeting one of his best-known songs before clarifying he was not condoning any reference to drugs some have seen in the song. Ravasi, an Italian who is the same age as Reed was when he died on Sunday, tweeted the third verse from Reed's song "Perfect Day". "Oh, it's such a perfect day/I'm glad I spent it with you/Oh, such a perfect day/You just keep me hanging on". ... Full Story | Top |
| Ohio says it will switch to new drugs for executions Monday, Oct 28, 2013 11:12 AM PDT By Kim Palmer CLEVELAND (Reuters) - Ohio said on Monday that it does not have enough of the drug pentobarbital to carry out a scheduled execution next month, the latest U.S. state to face a scarcity after the European manufacturer banned its sale for lethal injections of prisoners sentenced to death. Ohio is one of a number of U.S. states which have been forced to look to new suppliers such as lightly regulated "compounding pharmacies," or turn to new drugs for executions because major pharmaceutical companies are opposed to use of their drugs in carrying out the death penalty. ... Full Story | Top |
| Merck's Januvia, animal health products slump; shares off Monday, Oct 28, 2013 10:36 AM PDT By Ransdell Pierson (Reuters) - Merck & Co Inc reported lower sales of its Januvia diabetes treatment, fresh evidence its biggest product is losing ground to newer drugs, and also spooked investors with falling quarterly sales of its animal health products. The company's shares dropped 2.6 percent, or $1.19, to $45.33 in afternoon trading. Merck's animal health brands, which typically prop up results, suffered a 2 percent sales decline in third quarter, hurt by the recent decision to suspend marketing of its Zilmax weight-gain feed supplement amid concerns it was causing lameness in cattle. ... Full Story | Top |
| Gay Lebanese singer with 'Freddie Mercury' edge fronts band Monday, Oct 28, 2013 10:08 AM PDT  By Shadi Bushra LONDON (Reuters) - A man singing about wanting to be another man's wife, pampering his children and cooking him dinner isn't all that unusual in this age of same-sex marriage and advancing gay rights. But for Mashrou' Leila, a Lebanese alternative rock band, there was quite a risk in making lead singer Hamed Sinno's sexuality as much a part of their act as danceable tunes and darkly satirical lyrics attacking the Middle Eastern mindset. ... Full Story | Top |
| Synta's shares fall after cancer drug shows less benefit Monday, Oct 28, 2013 09:31 AM PDT By Vrinda Manocha (Reuters) - Shares of Synta Pharmaceuticals Corp fell 21 percent on Monday after updated data from a mid-stage lung cancer trial showed that its drug had less clinical benefit than previously reported. The drug, ganetespib, reduced the chance of death in patients by 25 percent, lower than the 39 percent the company announced in June from an earlier analysis. The company presented the latest data over the weekend. "The magnitude of the survival benefit is getting smaller," Stifel Nicolaus analyst Brian Klein told Reuters. "The risk for the drug's success has gone up. ... Full Story | Top |
| Doctor convicted in Michael Jackson death leaves prison Monday, Oct 28, 2013 09:15 AM PDT  By Eric Kelsey and Jonathan Alcorn LOS ANGELES (Reuters) - Michael Jackson's personal physician, convicted of manslaughter for administering a lethal dose of anesthetic to the pop singer, was released from a Los Angeles prison on Monday after serving half of his four-year sentence. Conrad Murray was released to his representatives, Los Angeles County Sheriff spokesman Steve Whitmore said shortly after Murray left the county jail. The release came under a California state plan to reduce prison overcrowding. ... Full Story | Top |
| Lundbeck gets U.S. approval for epilepsy drug for children Monday, Oct 28, 2013 08:09 AM PDT COPENHAGEN (Reuters) - Danish pharmaceutical group Lundbeck has won approval in the United States of its epilepsy drug, Sabril, to be used in children aged 10 years and older. Lundbeck said in a statement on Monday the United States Food and Drug Administration (FDA) had approved Sabril as an add-on therapy for the treatment of refractory complex partial seizures in children who have inadequately responded to several other treatments. (Reporting by Mette Fraende; editing by David Evans) Full Story | Top |
| Biogen's new MS drug tops expectations; ups 2013 forecast Monday, Oct 28, 2013 08:07 AM PDT  By Bill Berkrot (Reuters) - Biogen Idec Inc on Monday reported $286 million in third-quarter sales of its high-profile new multiple sclerosis drug Tecfidera, providing fresh evidence that the medicine is off to an impressive launch and exceeding all expectations. The company also reported higher-than-expected third-quarter earnings and raised its full-year profit and revenue forecasts, and its shares rose nearly 4 percent before paring gains. ... Full Story | Top |
|
No comments:
Post a Comment